What does Fate Therapeutics, Inc. do?

Jun 22 2025 06:39 PM IST
share
Share Via
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing programmed cellular immunotherapies for cancer and immune disorders. As of March 2025, it has a market cap of $137.56 million, with net sales of $2 million and a net loss of $38 million.
Overview:
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular immunotherapies for cancer and immune disorders, operating within the Pharmaceuticals & Biotechnology industry and categorized as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 2 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -38 Million (Quarterly Results - Mar 2025)
Market cap: USD 137.56 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.81
Return on Equity: -56.74%
Price to Book: 0.48

Contact Details:
Address: 3535 General Atomics Ct Ste 200, SAN DIEGO CA: 92121-1140
Tel: ['1 858 8751803', '1 212 3621200']
Fax: 1 302 6365454
Website: http://fatetherapeutics.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Fate Therapeutics, Inc. technically bullish or bearish?
Sep 20 2025 07:42 PM IST
share
Share Via
Is Fate Therapeutics, Inc. technically bullish or bearish?
Jun 25 2025 08:45 AM IST
share
Share Via
Who are in the management team of Fate Therapeutics, Inc.?
Jun 22 2025 10:29 PM IST
share
Share Via
How big is Fate Therapeutics, Inc.?
Jun 22 2025 05:58 PM IST
share
Share Via